DES awareness and exposure: The 1994 California Behavioral Risk Factor Survey

American Journal of Preventive Medicine

Volumn 12, Issue 5, 1996, Pages 442-446

  Wingard, D L ^a   Cohn, B A ^a   Helmrich, S P ^a   Edelstein, S L ^a  

^a Women's/Children's Health Res Ctr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; CANCER; DRUG EXPOSURE; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; REVIEW; RISK;

EID: 0029858314     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-3797(18)30305-2     Document Type: Review

References (17)

1. Smith O.W. Diethylstilbestrol in the prevention and treatment of complications of pregnancy Am J Obstet Gynecol 56 1948 821 834
2. Dieckmann W.J. Davis M.E. Rynkiewicz L.M. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 66 1953 1062 1081
3. Fergeson J.H. Effect of stilbestrol on pregnancy compared to the effect of placebo Am J Obstet Gynecol 65 1953 592 601
4. Herbst A.L. Ulfelder J. Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women N Engl J Med 284 1971 878 881
5. Melnick S. Cole P. Anderson D. Rate and risk of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix N Engl J Med 316 1987 514 516
6. Kaufman R.H. Adam E. Binder G.L. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol Am J Obstet Gynecol 137 1980 299 308
7. Jeffries J.A. Robboy S.J. O Brien P.C. Structural abnormalities of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project Am J Obstet Gynecol 148 1984 59 66
8. Linn S. Lieberman E. Schoenbaum S.C. Adverse outcomes of pregnancy in women exposed to diethylstilbestrol in utero I Reprod Med 33 1988 3 7
9. Thorp J.M. Jr. Fowler W.C. Donehoo R. Antepartum and intrapartum events in women exposed in utero to diethylstilbestrol Obstet Gynecol 76 5 pt l 1990 828 832
10. Stillman R.J. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance of male and female offspring Am J Obstet Gynecol 142 1982 905 921
11. Guisti RM, ed. Long-term health effects of exposure to diethylstilbestrol (DES): results of an NIH Workshop. Bethesda, Maryland. April 22-24, 1992.
12. Gill W.B. Schumacher G.R.B. Hubby M.M. Male genital tract changes in humans following intrauterine exposure to diethylstilbestrol Herbst A.L. Bern H.A. Developmental effects of diethylstilbestrol (DES) in pregnancy 1981 Thieme-Stratton, Inc. New York
13. Greenberg E.R. Barnes A.B. Resseguie L. Breast cancer in mothers given diethylstilbestrol in pregnancy N Engl J Med 311 1984 1393 1398
14. Colton T. Greenberg E.R. Noller K. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up JAMA 269 1993 2096 2100
15. Tilley B.C. Barnes A.B. Bergstralh E. A comparison of pregnancy history recall and medical records: implications for retrospective studies Am J Epidemiol 121 1985 269 281
16. Gentry E.M. Kalsbeek W.D. Hogelin G.C. The behavioral risk factor surveys. II. Design, methods, and estimates from combined state data Am J Prev Med 1 1985 9 14
17. Schiller G. Davis B. Perkins C. Lund L. California Behavioral Risk Factor Surveillance System SAS dataset documentation and technical report March 1995 Cancer Surveillance Section, California Department of Health Services Sacramento